Lexicon Pharmaceuticals
LXRX
LXRX
115 hedge funds and large institutions have $445M invested in Lexicon Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 103 → 115 (+12)
4.47% more ownership
Funds ownership: 96.38% → 100.86% (+4.5%)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
Holders
115
Holding in Top 10
3
Calls
$1.74M
Puts
$928K
Top Buyers
| 1 | +$3.59M | |
| 2 | +$3.53M | |
| 3 | +$2.87M | |
| 4 |
Bank of New York Mellon
New York
|
+$2.53M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.26M |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1.84M | |
| 3 | -$1.59M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$892K |
| 5 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$611K |